|
BNIP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.20739999999831E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.643300E-04 |
| Normal-vs-Stage2 |
1.38110000003078E-06 |
| Normal-vs-Stage3 |
1.633570E-04 |
| Normal-vs-Stage4 |
2.07190000000024E-05 |
| Stage1-vs-Stage2 |
1.831820E-02 |
| Stage1-vs-Stage3 |
4.258400E-01 |
| Stage1-vs-Stage4 |
7.765800E-02 |
| Stage2-vs-Stage3 |
1.691400E-01 |
| Stage2-vs-Stage4 |
6.110200E-01 |
| Stage3-vs-Stage4 |
3.805000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.628800E-04 |
| Normal-vs-AfricanAmerican |
1.497730E-03 |
| Normal-vs-Asian |
1.184340E-03 |
| Caucasian-vs-AfricanAmerican |
5.269200E-01 |
| Caucasian-vs-Asian |
7.694600E-01 |
| AfricanAmerican-vs-Asian |
6.937600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.955800E-04 |
| Normal-vs-Female |
2.65040000002603E-06 |
| Male-vs-Female |
2.827000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.057690E-03 |
| Normal-vs-Age(41-60Yrs) |
3.99910000004056E-06 |
| Normal-vs-Age(61-80Yrs) |
1.96350999999151E-05 |
| Normal-vs-Age(81-100Yrs) |
3.998800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.034000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.337700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.134400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.229400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.288000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.439400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.078200E-02 |
| Classical-VS-Follicular |
2.45999999999302E-05 |
| Classical-VS-Other |
9.296400E-01 |
| Classical-VS-Normal |
1.738770E-03 |
| Tall-VS-Follicular |
6.735600E-01 |
| Tall-VS-Other |
3.453600E-01 |
| Tall-VS-Normal |
4.025600E-04 |
| Follicular-VS-Other |
1.550200E-01 |
| Follicular-VS-Normal |
4.6483000004649E-08 |
| Other-VS-Normal |
2.228400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.50010000269319E-08 |
| Normal-vs-N1 |
7.356800E-03 |
| N0-vs-N1 |
6.246400E-02 |
|
|
